Company profile
DB · companies + sec_company_profileGilead Sciences, Inc. (GILD) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolGILD
- Legal nameGilead Sciences, Inc.
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0000882095
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$163.41B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG000CKGBP2
- CountryUS
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Daniel O'Day | Chairman & Chief Executive Officer | $8.7M | 1965 | — |
| Dietmar Berger | Chief Medical Officer | $5.92M | 1969 | — |
| Johanna Mercier | Chief Commercial & Corporate Affairs Officer | $3.44M | 1970 | — |
| Andrew D. Dickinson | Chief Financial Officer | $3.14M | 1970 | — |
| Flavius Martin | Executive Vice President of Research | — | — | — |
| Jackson Egen | Vice President of Research Oncology | — | — | — |
| Jacquie Ross | Senior Vice President of Treasury and Investor Relations | — | — | — |
| Janet Dorling | Senior Vice President of Intercontinental Region & Global Patient Solutions | — | 1975 | — |